Clinical Trials Directory

Trials / Conditions / Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma

Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma

6 registered clinical trials studyying Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma.

StatusTrialSponsorPhase
TerminatedTesting the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Ci
NCT04458909
National Cancer Institute (NCI)Phase 3
TerminatedStereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
NCT02388932
Case Comprehensive Cancer CenterN/A
CompletedLenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
NCT01254617
National Cancer Institute (NCI)Phase 1
CompletedTemsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who D
NCT01256385
National Cancer Institute (NCI)Phase 2
CompletedCediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
NCT00458978
National Cancer Institute (NCI)Phase 2
Active Not RecruitingVorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or
NCT00336063
National Cancer Institute (NCI)Phase 1